IIgGenix Team
IgGenix
Last updated: February 23, 2026
Develop first-in-class therapies for millions of people whose daily lives are limited by allergies Biotech
Khosla Ventures, $40M Series B in 2023
Develop first-in-class therapies for millions of people whose daily lives are limited by allergies Biotech
Khosla Ventures, $40M Series B in 2023
- Series B • Khosla Ventures, $40M Series B in 2023
Founder Intelligence Brief: IgGenix Team
This profile is built to help readers move from a founder name to decision-ready context. IgGenix Team is mapped to IgGenix in the Startup category, with current stage context as Series B. The primary operating market is San Francisco Bay Area, California, USA, which connects this profile directly to regional ecosystem pages and related industry hubs.
Funding visibility currently shows $40.00M, with the latest mapped round as Series B (Khosla Ventures, $40M Series B in 2023). This makes it easier to evaluate growth narrative against capital stage rather than reading isolated updates without baseline context.
For deeper research, combine this founder page with the company profile, company news hub, country newsroom and Startup startup list. This route gives a cleaner picture of execution, market demand, and competitive movement.
Research flow
- Validate company baseline on company intelligence.
- Compare market peers via Startup industry routes and Series B stage pages.
- Track fresh updates in newsroom coverage and signals feed.
Operating context
- Geography: United States directory.
- Stage signal: Series B funding coverage.
- Hiring status: Open Roles.
Related Founders
More founders in Startup.
Want to get featured on 100Xfounder?
Get your founder profile published with verified funding and hiring context.
Related Pillar Pages
Access the country, industry, stage, startup taxonomy, and newsroom routes connected to this founder.
FAQs About IgGenix Team
Common questions people ask about this profile.
Who is IgGenix Team?
IgGenix Team is the founder profile listed on 100Xfounder for IgGenix, tracked for market signals, company intelligence, and operator-level context.
What does IgGenix do?
Develop first-in-class therapies for millions of people whose daily lives are limited by allergies Biotech
Where is IgGenix based?
IgGenix is listed as operating from San Francisco Bay Area, California, USA.
What is the current funding stage of IgGenix?
IgGenix is currently categorized at Series B on 100Xfounder. Funding signal: Khosla Ventures, $40M Series B in 2023
What is the latest funding round for IgGenix?
The latest tracked round for IgGenix is Series B Khosla Ventures, $40M Series B in 2023. Total tracked rounds: 1.
Is IgGenix hiring right now?
Current hiring signal for IgGenix: Open Roles.
Is IgGenix Team's profile verified?
Yes. IgGenix Team's profile is marked as verified on 100Xfounder as of March 3, 2026.
How can I connect with IgGenix Team?
You can use the profile action buttons and listed links on 100Xfounder. Contact context is provided with business relevance and profile metadata for iggenix.com.
What technologies are associated with IgGenix?
IgGenix is associated with AWS, React, Python, and PostgreSQL based on current profile intelligence.